Analysis of β-tubulin gene alteration in human lung cancer cell lines

Cancer Letters

Volumn 201, Issue 2, 2003, Pages 211-216

  Achiwa, Hiroyuki ^a,b   Sato, Shigeki ^a   Shimizu, Shigeki ^a,b   Maeda, Hiroyoshi ^a   Niimi, Takashi ^a   Takahashi, Takashi ^b   Ueda, Ryuzo ^a   Mitsudomi, Tetsuya ^b  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Lung cancer; Mutation; Pseudogene; Taxanes; tubulin

Indexed keywords

BETA TUBULIN; GENOMIC DNA; TAXANE DERIVATIVE;

ADENOSQUAMOUS CARCINOMA; ARTICLE; CANCER CELL CULTURE; CODON; DNA DETERMINATION; EXON; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; INTRON; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; SILENT GENE;

EID: 0242321138     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00473-7     Document Type: Article

References (20)

1. Breathnach O.S., Freidlin B., Conley B., Green M.R., Johnson D.H., Gandara D.R., O'Connell M., Shepherd F.A., Johnson B.E. Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results. J. Clin. Oncol. 19:2001;1734-1742.
2. Schiller J.H., Harrington D., Belani C.P., Langer C., Sandler A., Krook J., Zhu J., Johnson D.H. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl. J. Med. 346:2002;92-98.
3. Schiff P.B., Fant J., Horwitz S.B. Promotion of microtubule assembly in vitro by taxol. Nature. 277:1979;665-667.
4. Schiff P.B., Horwitz S.B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl Acad. Sci. USA. 77:1980;1561-1565.
5. Jordan M.A., Wilson L. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr. Opin. Cell Biol. 10:1998;123-130.
6. Lee M.G., Lewis S.A., Wilde C.D., Cowan N.J. Evolutionary history of a multigene family: an expressed human beta-tubulin gene and three processed pseudogenes. Cell. 33:1983;477-487.
7. Burkhart C.A., Kavallaris M., Horwitz S.B. The role of beta-tubulin isotypes in resistance to antimitotic drugs. Biochim. Biophys. Acta. 1471:2001;O1-O9.
8. Ranganathan S., Dexter D.W., Benetatos C.A., Chapman A.E., Tew K.D., Hudes G.R. Increase of beta(III)- and beta(IVa)-tubulin isotopes in human prostate carcinoma cells as a result of estramustine resistance. Cancer Res. 56:1996;2584-2589.
9. Ranganathan S., Benetatos C.A., Colarusso P.J., Dexter D.W., Hudes G.R. Altered beta-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells. Br. J. Cancer. 77:1998;562-566.
10. Kavallaris M., Kuo D.Y., Burkhart C.A., Regl D.L., Norris M.D., Haber M., Horwitz S.B. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. J. Clin. Invest. 100:1997;1282-1293.
11. Schibler M.J., Cabral F. Taxol-dependent mutants of Chinese hamster ovary cells with alterations in alpha- and beta-tubulin. J. Cell Biol. 102:1986;1522-1531.
12. Giannakakou P., Sackett D.L., Kang Y.K., Zhan Z., Buters J.T., Fojo T., Poruchynsky M.S. Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization. J. Biol. Chem. 272:1997;17118-17125.
13. Gonzalez-Garay M.L., Chang L., Blade K., Menick D.R., Cabral F. A beta-tubulin leucine cluster involved in microtubule assembly and paclitaxel resistance. J. Biol. Chem. 274:1999;23875-23882.
14. Giannakakou P., Gussio R., Nogales E., Downing K.H., Zaharevitz D., Bollbuck B., Poy G., Sackett D., Nicolaou K.C., Fojo T. A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells. Proc. Natl Acad. Sci. USA. 97:2000;2904-2909.
15. Monzo M., Rosell R., Sanchez J.J., Lee J.S., O'Brate A., Gonzalez-Larriba J.L., Alberola V., Lorenzo J.C., Nunez L., Ro J.Y., Martin C. Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutations. J. Clin. Oncol. 17:1999;1786-1793.
16. Luduena R.F. Multiple forms of tubulin: different gene products and covalent modifications. Int. Rev. Cytol. 178:1998;207-275.
17. Wilde C.D., Crowther C.E., Cripe T.P., Gwo-Shu Lee M., Cowan N.J. Evidence that a human beta-tubulin pseudogene is derived from its corresponding mRNA. Nature. 297:1982;83-84.
18. Kelley M.J., Li S., Harpole D.H. Genetic analysis of the beta-tubulin gene, TUBB, in non-small-cell lung cancer. J. Natl Cancer Inst. 93:2001;1886-1888.
19. Tsurutani J., Komiya T., Uejima H., Tada H., Syunichi N., Oka M., Kohno S., Fukuoka M., Nakagawa K. Mutational analysis of the beta-tubulin gene in lung cancer. Lung Cancer. 35:2002;11-16.
20. Sale S., Sung R., Shen P., Yu K., Wang Y., Duran G.E., Kim J.H., Fojo T., Oefner P.J., Sikic B.I. Conservation of the class I β-tubulin gene in human populations and lack of mutations in lung cancers and paclitaxel- resistant ovarian cancers. Mol. Cancer Ther. 1:2002;215-225.